BMI Metrics Are Poor Predictors of Pediatric Nonalcoholic Fatty Liver Disease Severity

Child Obes. 2023 Mar;19(2):139-143. doi: 10.1089/chi.2021.0316. Epub 2022 Apr 26.

Abstract

Background: Alternative BMI metrics are superior to BMI z score (BMIz) in tracking obesity but have not been evaluated in patients with nonalcoholic fatty liver disease (NAFLD). Our objective was to evaluate whether BMI-adjusted z score (BMIaz) or BMI expressed as a percentage of the 95th percentile (%BMIp95) are better predictors of degree of alanine aminotransferase (ALT) elevation, a surrogate for NAFLD severity, compared with BMIz in patients with NAFLD. Methods: A retrospective study of 776 subjects aged 2-18 years with BMIz > 1.0 followed in a NAFLD subspecialty clinic was conducted. Regression analysis was used to determine predictors of elevated ALT. Results: There was no association between BMIz, BMIaz, or %BMIp95 and degree of ALT elevation using linear or logistic regression. Conclusion: These results do not support the use of alternative BMI metrics for evaluating NAFLD severity. Future studies should investigate longitudinal assessments and correlation with histology.

Keywords: BMI; BMI z score; NAFLD; NASH; obesity.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Alanine Transaminase
  • Body Mass Index
  • Child
  • Humans
  • Logistic Models
  • Non-alcoholic Fatty Liver Disease*
  • Pediatric Obesity*
  • Retrospective Studies

Substances

  • Alanine Transaminase